Researchers incubated J3’s in the absence of Unknown Factor X. Upon the addition of a membrane-permeant cGMP agonist (a cGMP agonist able to penetrate into the J3’s) you would expect to see STIMULATION/INHIBITION (highlight one) of the J3 activation pathway. 2. Researchers incubated J3’s in the presence of Unknown Factor X, but with the addition of a membrane-permeant CYP antagonist. In this case, you would expect to see STIMULATION/INHIBITION (highlight one) of the J3 activation pathway.

Researchers incubated J3’s in the absence of Unknown Factor X. Upon the addition of a membrane-permeant cGMP agonist (a cGMP agonist able to penetrate into the J3’s) you would expect to see STIMULATION/INHIBITION (highlight one) of the J3 activation pathway. 2. Researchers incubated J3’s in the presence of Unknown Factor X, but with the addition of a membrane-permeant CYP antagonist. In this case, you would expect to see STIMULATION/INHIBITION (highlight one) of the J3 activation pathway.

Biology 2e

2nd Edition

ISBN:9781947172517

Author:Matthew Douglas, Jung Choi, Mary Ann Clark

Publisher:Matthew Douglas, Jung Choi, Mary Ann Clark

Chapter9: Cell Communication

Section: Chapter Questions

Problem 12RQ: Histamine binds to the H1 G-protein-linked receptor to initiate the itchiness and airway...

See similar textbooks

Similar questions

The drug Celebrex selectively inhibits PTGS2 while aspirin and other NSAID’s inhibit both PTGS1 and PTGS2 in the same way. Why do you think researchers wanted to discover a selective inhibitor to PTGS2?
Some drugs and toxic compounds interfere with removal of neurotransmitters from the synaptic cleft once they have been released. (1) Explain the two basic mechanisms affected by Sarin nerve gas and the drug Prozac. (2) If you were investigating an autoimmune disease that appeared to interfere with removal of neurotransmitters from the synaptic cleft, and you were able to isolate the causative antibody from the patient's serum, how could you use that antibody to investigate whether it affected one of the two inactivation mechanisms?
In relation to Cushing’s Syndrome, a method that some scientists have used to treat the disease is to use small molecules that bind to, but do not activate, MC2R. This type of molecule is considered an antagonist. How can an antagonist bind to the same receptor as ACTH but not activate it ? a. The antagonist binds covalently while ACTH binds non covalently b. The antagonist is only partially complimentary to the binding pocket of MC2R c. The antagonist binds to ACTH and blocks it from binding to the receptor properly d. The antagonist is the exact same structure as ACTH but since it is synthetic it doesn’t work
1. A mutation was introduced to the active site of the enzyme in a receptor tyrosine kinase so that it remains active in the absence of a substrate. What is the effect of this mutation on the signal transductionpathway?A. The phosphatase activity of the enzyme will be activated which will lead to receptor dimerization and subsequent cellular response.B. The signal molecule will bind to the receptor and dimerization will occur but the subsequent cellular response will be inhibited.C. The signal molecule will bind to the receptor but dimerization and subsequent cellular response will be inhibited.D. The signal molecule will bind to the receptor which will then triggers receptor dimerization and downstream cellular response. 2. Which of the following is not an advantage of non-coding regions of DNA?A. Some of these regions contain inactivated genes that can be reactivated upon insertion of regulatory sequences by mobile DNA elements.B. Some of these regions protect eukaryotic DNA from…
EGF signals by binding to cell surface EGF receptors. Which of these observations, if true, would BEST explain EGF’s mechanism of action? A. EGF is hydrophilic and can easily diffuse through the cell membrane B. EGF is hydrophobic and can easily diffuse through the cell membrane C. EGF is hydrophilic and cannot diffuse through the cell membrane D. EGF is hydrophobic and cannot diffuse through the cell membrane
A scientist observes a mutation in the transmembrane region of EGFR that eliminates its ability to be stabilized by binding interactions during dimerization after ligand binding. Which hypothesis regarding the effect of this mutation on EGF signaling is most likely to be correct? EGF signaling cascades would be active for longer in the cell. EGF signaling cascades would be active for a shorter period of time in the cell. EGF signaling cascades would not occur. EGF signaling would be unaffected.
Histamine binds to the H1 G-protein-linked receptor to initiate the itchiness and airway constriction associated with an allergic response. If a mutation in the associated G-protein’s alpha subunit prevented the hydrolysis of GTP how would the allergic response change? More severe allergic response compared to normal G-protein signaling. Less severe allergic response compared to normal G-protein signaling. No allergic response. No change compared to normal G-protein signaling.
40. Notch receptors operate through juxtacrine signaling which requires A. close physical association between the signal-emitting and signal-receiving cells B. cells far away from each other communicating through chemical messengers C. a cell to release a ligand that binds to a receptor on its own surface D. None of the above
Design a novel drug for treatment for overactive bladder syndrome which does not target the muscarinic M3 receptors directly, but rather targets one of the second messenger signalling molecules within the smooth muscle cells as a result of muscarinic M3 receptor activation. Which second messenger molecule would you choose to target? Justify your choice and explain how targeting this second messenger pathway would result in the reduction of bladder smooth muscle contraction.
1a.Arrange these ligands in their order of potencies(high to low) 1b. Choose an appropriate concentration of Propranolol needed to block 50% of epinephrine or isoproterenol induced cAMP production via adrenergic receptors expressed in a cell culture model system. 1c. Which of the following has more affinity to bind to adrenergic receptors? And why?I. EpinephrineII. IsoproterenolIII. Propranolol
How will you exploit the effector proteins of Type 3 and Type 4 secretion systems to develop novel therapeutics and drugs. Please be specific to Type 3and 4 systems, respectively. Please give 10 key points.
We saw that GPCRs have a basal level of constitutive activity. Not all receptors do. Why might having this constitutive activity be a benefit to the cells?